Trivadi S. Ganesan

Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C

David Propper, A. McDonald, A. Man et al. · Journal of Clinical Oncology · 2001 · 233 citations

Pharmacy, Oncology, Pharmacology +15

A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer

Srinivasan Madhusudan, Martin D. Foster, S. Muthuramalingam et al. · Clinical Cancer Research · 2004 · 204 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor   Induction In Vivo

P. A. Philip, Daniel Rea, P. Thavasu et al. · JNCI Journal of the National Cancer Institute · 1993 · 187 citations

Medicine, Oncology, Pharmacology +15

Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer

Srinivasan Madhusudan, S. Muthuramalingam, Jeremy Braybrooke et al. · Journal of Clinical Oncology · 2005 · 166 citations

Medicine, Oncology, Pharmacology +17

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

Gordon Rustin, Gavin Shreeves, Paul Nathan et al. · British Journal of Cancer · 2010 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17